You are here: Industry Insights > Lonza

News List

Lonza, Sanquin Reagents Enter Strategic Pact contractpharma
May 29, 2020
Expands Lonza’s portfolio of endotoxin testing products and enables drug developers and QC labs to leverage sustainable MAT method.
Noga Therapeutics and Lonza to develop Autologous Lentiviral Gene Therapy on the Cocoon Platform expresspharma
May 13, 2020
The Cocoon Platform is a closed, highly customizable and scalable platform with minimal touchpoints, which will help Noga Therapeutics to accelerate the development of lentiviral gene therapies.
Moderna signs ten-year vaccine manufacturing deal with Lonza pharmaceutical-technology
May 04, 2020
Moderna has signed a ten-year agreement with Lonza for large-scale manufacture of its vaccine candidate, mRNA-1273, against Covid-19 and other products in the future.
Lonza Launches TheraPEAK SfAAV Medium contractpharma
March 24, 2020
Designed specifically for production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells for gene therapy applications.
Citryll, Lonza Enter Manufacturing Partnership contractpharma
September 12, 2019
The Netherlands-based biotech Citryll and contract development and manufacturing organization (CDMO) Lonza have entered a partnership to develop and manufacture Citryll’s tACPA therapeutic antibody CIT-013.
Celltrion, Lonza Sign Contract to Manufacture Remsima Drug Substance contractpharma
September 04, 2019
Lonza’s biologics facility in Singapore to cover EU and U.S. market needs.
Omeros, Lonza Enter Commercial Manufacturing Agreement contractpharma
August 01, 2019
Builds on existing clinical supply deal for narsoplimab.
Lonza, Vineti Enter Cell and Gene Therapy Network Alliance contractpharma
July 31, 2019
Integrated offering includes logistics, scheduling, distribution, Chain of Condition, Chain of Custody, Chain of Identity, and Lonza’s MODA-ES.
Lonza expanding ADC production as pharma business thrives fiercepharma
July 28, 2019
Swiss CDMO may be struggling in some areas, but it is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth.
Lonza expands its bioconjugation facility in Visp, Switzerland expresspharma
July 25, 2019
Lonza’s expansion will meet development, manufacturing needs of pharma and biotech companies developing a new generation of therapies

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page